Clinical Trial Update: Focal HDR Brachytherapy Boost to Stereotactic Radiotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating focal HDR brachytherapy boost to stereotactic radiotherapy for prostate cancer; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Prostate Cancer | Phase 2 | Status: RECRUITING